Search

everythinglearnresearchcommunity

for

Search:↓

Some women with PCOS have rare genetic variants linked to the condition.

The woman was misdiagnosed with Graves Disease, leading to incorrect treatment, while she actually had Pituitary Resistance to Thyroid Hormone.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

A woman's increased hair growth during pregnancy due to PCOS resolved after delivery.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Doctors need to be better prepared to assess and treat obesity in patients.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Finasteride safely reduces excessive hair growth in women.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Human scalp hair follicles can be used to study how prolactin affects hair growth and cell death.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Hormones and genes affect hair growth and male baldness.